跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
E-64
首页
药物
E-64
E-64
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
68 Ga- and 64 Cu-NODAGA-E[c(RGDyK)] 2 for use as PET tracers in the imaging of angiogenesis in humans
申请人: RIGSHOSPITALET
优先权: 2017
US
ENGINEERED SPLIT LUCIFERASES
申请人: MONOD BIO INC
优先权: 2024
WO
Medicament for preventing or treating tumors caused by human papilloma virus type 18
申请人: MULLER RAINER
优先权: 2000
US
Compositions and methods for detecting protein sulfenylation
申请人: UNIV MICHIGAN REGENTS
优先权: 2015
US
STEVIA PLANT WITH HIGH CONTENT OF REBAUDIOSIDE E
申请人: SUNTORY HOLDINGS LTD
优先权: 2020
CN
US
WO
3 件公开
Bovine enterovirus type 1 isolated strain and application thereof
申请人: NANYANG NORMAL SCHOOL
优先权: 2022
CN
ASSAY SYSTEM FOR DEVELOPING HONEYBEE ANTIVIRAL AGENT USING INHIBITION OF VIRUS-DERIVED PROTEASE AS INDICATOR
申请人: UNIV TOYAMA PREFECTURAL
优先权: 2023
CN
EP
US
WO
4 件公开
A blood-tonifying antiaging and speckle-removing facial cleanser
申请人: WU CHENGBIN
优先权: 2017
CN
药物
反馈